[Federal Register Volume 80, Number 10 (Thursday, January 15, 2015)]
[Notices]
[Pages 2107-2108]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-00519]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: National Vaccine Program Office, Office of the Assistant 
Secretary for Health, Office of the Secretary, Department of Health and 
Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) will hold a meeting 
February 10-11, 2015. The meeting is open to the public. However, pre-
registration is required for both public attendance and public comment. 
Individuals who wish to attend the meeting and/or participate in the 
public comment session should register at http://www.hhs.gov/nvpo/nvac. 
Participants may also register by emailing <a href="/cdn-cgi/l/email-protection#cfa1b9bfa08fa7a7bce1a8a0b9"><span class="__cf_email__" data-cfemail="ed839b9d82ad85859ec38a829b">[email protected]</span></a> or by calling 
202-690-5566 to provide your name, organization, and email address.

DATES: The meeting will be held on February 10-11, 2015. The meeting 
times and agenda will be posted on the NVAC Web site at http://www.hhs.gov/nvpo/nvac as soon they become available.

ADDRESSES: U.S. Department of Health and Human Services, Hubert H. 
Humphrey Building, Great Hall, 200 Independence Avenue SW., Washington, 
DC 20201.

[[Page 2108]]

    The meeting can also be accessed through a live webcast the day of 
the meeting. For more information, visit http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/index.html.

FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, U.S. 
Department of Health and Human Services, Room 715-H, Hubert H. Humphrey 
Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: 
(202) 690-5566; email: <a href="/cdn-cgi/l/email-protection#107e66607f507878633e777f66"><span class="__cf_email__" data-cfemail="8ae4fcfae5cae2e2f9a4ede5fc">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and 
Human Services was mandated to establish the National Vaccine Program 
to achieve optimal prevention of human infectious diseases through 
immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The NVAC was established to provide advice and 
make recommendations to the Director of the National Vaccine Program on 
matters related to the Program's responsibilities. The Assistant 
Secretary for Health serves as Director of the National Vaccine 
Program.
    The topics planned for the February NVAC meeting will include a 
number of sessions addressing vaccine innovation. The NVAC will hear 
about current U.S. government-wide strategies to combat antimicrobial 
resistance followed by a panel discussion on the role vaccines (both 
existing and new) could play in those strategies. The Institute of 
Medicine will present their recently released report on the Strategic 
Multi-Attribute Ranking Tool for Vaccines (SMART-Vaccines) software 
developed to support prioritization of new vaccine research and 
development. NVAC will then hear from beta-testers of the SMART-Vaccine 
software about their experience and possible uses for the tool going 
forward. NVAC will also discuss the on-going efforts to better 
understand and overcome the barriers to sharing immunization registry 
data between states.
    NVAC will preview both the National Vaccine Annual Report and the 
National Adult Immunization Plan. In addition, the Vaccine Confidence/
Acceptance and the NVAC HPV working groups will present their draft 
report and draft recommendations for NVAC consideration and discussion. 
Finally, the NVAC Maternal Immunization and the NVAC Mid-Course Review 
Working Groups will provide an update on their progress. The meeting 
agenda will be posted on the NVAC Web site: http://www.hhs.gov/nvpo/nvac prior to the meeting.
    Public attendance at the meeting is limited to the available space. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the National Vaccine Program Office at the address/phone listed 
above at least one week prior to the meeting. For those unable to 
attend in person, a live webcast will be available. More information on 
registration and accessing the webcast can be found at http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/index.html.
    Members of the public will have the opportunity to provide comments 
at the NVAC meeting during the public comment periods designated on the 
agenda. Individuals who would like to submit written statements should 
email their comments to the National Vaccine Program Office 
(<a href="/cdn-cgi/l/email-protection#79170f09163911110a571e160f"><span class="__cf_email__" data-cfemail="f19f87819eb1999982df969e87">[email protected]</span></a>) at least five business days prior to the meeting.

    Dated: 12 January 2015.
Bruce Gellin,
Executive Secretary, National Vaccine Advisory Committee, Deputy 
Assistant Secretary for Health, Director, National Vaccine Program 
Office.
[FR Doc. 2015-00519 Filed 1-14-15; 8:45 am]
BILLING CODE 4150-44-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>